Repositioning Irsogladine to Hsp90 Inhibitor

Publisher： John Wiley & Sons Inc

E-ISSN： 1229-5949|36|5|1495-1499

ISSN： 1229-5949

Source： BULLETIN OF THE KOREAN CHEMICAL SOCIETY (ELECTRONIC), Vol.36, Iss.5, 2015-05, pp. : 1495-1499

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radiosensitization of human lung cancer cells by the novel purine-scaffold Hsp90 inhibitor, PU-H71

By              

International Journal of Molecular Medicine, Vol. 33, Iss. 3, 2014-01 ,pp. : 559-564

Spandidos Publications

Access to resources Recommend Favorite

HSP90 mitochondriale

By Didelot Céline   Garrido Carmen  

Médecine/sciences, Vol. 24, Iss. 4, 2010-12 ,pp. : 363-364

Edp Sciences

Access to resources Recommend Favorite

Extracellular HSP90: An Emerging Target for Cancer Therapy

By  

Current Signal Transduction Therapy, Vol. 4, Iss. 1, 2009-01 ,pp. : 51-58

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting multiple signal transduction pathways through inhibition of Hsp90

By Zhang Hong   Burrows Francis  

Journal of Molecular Medicine, Vol. 82, Iss. 8, 2004-08 ,pp. : 488-499

Springer Publishing Company

Access to resources Recommend Favorite

Ethoxyquin prevents chemotherapy‐induced neurotoxicity via Hsp90 modulation

By  

ANNALS OF NEUROLOGY, Vol. 74, Iss. 6, 2013-12 ,pp. : 893-904

John Wiley & Sons Inc

Access to resources Recommend Favorite